4.5 Letter

Comment on 'Oral ivermectin to treat scabies: a comparison of two different regimens'

期刊

CLINICAL AND EXPERIMENTAL DERMATOLOGY
卷 48, 期 6, 页码 695-696

出版社

OXFORD UNIV PRESS
DOI: 10.1093/ced/llad060

关键词

-

向作者/读者索取更多资源

Current guidelines recommend oral ivermectin as the first-line treatment, with a dose of 200 μg/kg taken in two doses 1-week apart (to be taken with food). However, the recently approved ivermectin formulation in Italy suggests a single dose. In response to this, we conducted a retrospective analysis at our Dermatological Clinic of Mycology and Parasitosis and present our findings, following a similar study conducted by Balestri et al.
Current guidelines recommended the use of oral ivermectin (taken with food) 200 mu g kg(-1) as two doses 1-week apart as the first-line treatment option; however, the drug package of the ivermectin formulation recently approved for the Italian market recommends a single dose. In this context, we read with great interest the article recently published by Balestri et al. comparing two regimens of oral ivermectin. Similarly, we performed a retrospective analysis at our Dermatological Clinic of Mycology and Parasitosis and report our results.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据